RareMed Expands Partnership with PTC Therapeutics to Enhance Access to Sephience Therapy for PKU Patients

RareMed Solutions is expanding its relationship with PTC Therapeutics to provide non-commercial pharmacy dispensing services for Sephience, a therapy for phenylketonuria (PKU). The RareSupport team is expanding to provide outreach and coordination efforts across PTC's supported therapies, ensuring seamless access and support for patients and healthcare providers. RareMed's commitment to providing care extends beyond therapy launches, aiming to facilitate a smoother treatment experience for all stakeholders involved.